Follow

Submissions from 2024

Link

A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers., Alain P Algazi, James Moon, Christopher D Lao, Bartosz Chmielowski, Kari L Kendra, Karl D Lewis, Rene Gonzalez, Kevin Kim, John E Godwin, Brendan D. Curti, Michaella Latkovic-Taber, Shirley H Lomeli, Brandon T Gufford, Philip O Scumpia, Roger S Lo, Megan Othus, and Antoni Ribas

Link

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study., Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel, Denise M Adams, Jillian Dayneka, Sally J Cohen-Cutler, Steven M Andreoli, Melinda D Wu, Allison P Wheeler, Kenneth M Heym, Shelley E Crary, Taizo A Nakano, Rachael R Schulte, Bhuvana A Setty, Thomas W McLean, Kristy S Pahl, Stefanos Intzes, Irina Pateva, Max Teitelbaum, Zili Zong, Yimei Li, and Michael R Jeng

Developing Combination Immunotherapy Trials with Vaccines that Contain Cancer’s Dark Matter, Bernard Fox

Link

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML., Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litzow, M Lynn Savoie, Bruno C Medeiros, Mikkael A Sekeres, Tara L Lin, Geoffrey L Uy, Bayard L Powell, Jonathan E Kolitz, Richard A Larson, Richard M Stone, David Claxton, James Essell, Selina M Luger, Sanjay R Mohan, Anna Moseley, Frederick R Appelbaum, and Harry P Erba

PDF

Population Screening for High-Risk Patient Identification Partnership with CARE-Comprehensive Assessment, Risk, and Education., Ora K Gordon, Brad Bott, Nanor Parseghian, Kimberly K Childers, and Sandra Brown

PDF

Multi-Cancer Early Detection Testing (MCED), Ora K Gordon, Brad Bott, Nanor Parseghian, Paul Psychogios, Kimberly K Childers, and Sandra Brown

Link

The RAPID Consortium: A Platform for Clinical and Translational Pituitary Tumor Research., Michael Karsy, Varun Kshettry, Paul Gardner, Michael Chicoine, Juan C Fernandez-Miranda, James J Evans, Garni Barkhoudarian, Douglas Hardesty, Won Kim, Gabriel Zada, Tomiko Crocker, Ildiko Torok, and Andrew Little

Link

The Dance Between Tumor Molecular Biology and Antitumor Immune Response., K A Margolin

Link

Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells., Hunter D Reavis, Stefan M Gysler, Grace B McKenney, Matthew Knarr, Hannah J Lusk, Priyanka Rawat, Hannah S Rendulich, Marilyn A Mitchell, Dara S Berger, Jamie Moon, Suyeon Ryu, Monica Mainigi, Marcin P Iwanicki, Dave Hoon, Laura M Sanchez, and Ronny Drapkin

Link

Management of Neurologic Complications in Patients with Brain and Spine Tumors., Alipi V Bonm and Lynne P Taylor

Submissions from 2023

Deep Learning Applications Using H&E Images Improve Clinical Sequencing Workflows, J Abel, Brian Piening, Carlo Bifulco, and See full list of authors in comments

Link

Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression., Orit Adir, Orit Sagi-Assif, Tsipi Meshel, Shlomit Ben-Menachem, Metsada Pasmanik-Chor, Dave Hoon, Isaac P Witz, and Sivan Izraely

Link

Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients., Boris Aguilar, Kawther Abdilleh, and George K Acquaah-Mensah

Link

Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With, Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukian, Charles W Drescher, Rui Li, Apostolia M Tsimberidou, Charles A Leath, Raegan O'Lone, Gina N Grantham, Susan Halabi, and Richard L Schilsky

Link

AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021-A survey of therapeutic medical physics residency program directors., Manik Aima, Samantha J Simiele, Susan L Richardson, and Christopher S Melhus

Link

Liquid biopsies and minimal residual disease in myeloid malignancies., Sabine Allam, Kristina Nasr, Farhan Khalid, Zunairah Shah, Mahammed Ziauddin Khan Suheb, Sana Mulla, Sindhu Vikash, Maroun Bou Zerdan, Faiz Anwer, and Chakra P Chaulagain

Link

Vemurafenib- and Cobimetinib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Metastatic Melanoma., Miriam Al-Saedy, Salsabeal Al-Saedy, and Chad Rieck

Link

Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population., Raed M Alsulaiman, Abdulaziz A Al-Quorain, Fahad A Al-Muhanna, Stanley Piotrowski, Ezzeddin A Kurdi, Chittibabu Vatte, Ahmed A Alquorain, Noorah H Alfaraj, Abdulaziz M Alrezuk, Fred L Robinson, Alexa K Dowdell, Turki A Alamri, Lauren Hamilton, Hetal Lad, Hui Gao, Divya Gandla, Brendan J Keating, Ryan Meng, Brian D. Piening, and Amein K Al-Ali

Link

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)., Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, Marc S Ernstoff, Bernard A Fox, Thomas F Gajewski, Jérôme Galon, Claus Garbe, Brian R Gastman, Jeffrey E Gershenwald, Pawel Kalinski, Michelle Krogsgaard, Rom S Leidner, Roger S Lo, Alexander M Menzies, Olivier Michielin, Poulikos I Poulikakos, Jeffrey S Weber, Corrado Caracò, Iman Osman, Igor Puzanov, and Magdalena Thurin

Link

The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022., Paolo A Ascierto, Renier Brentjens, Samir N Khleif, Kunle Odunsi, Katayoun Rezvani, Marco Ruella, Ryan J Sullivan, Bernard A Fox, and Igor Puzanov

Link

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial., Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, James Larkin, Georgina V Long, Rachel E Sanborn, Vanna Chiarion-Sileni, Brigitte Dréno, Stéphane Dalle, Dirk Schadendorf, Margaret K Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez-Roca, Naoya Yamazaki, Hussein A Tawbi, Naomey Sarkis, Deepti Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, and Jean-Jacques Grob

Link

Rare presence of Charcot-Leyden crystals in acute myeloid leukemia., Sujan Badal, Mahnoosh Taheri, Peter Jiang, and Kirstine Oh

Link

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma., Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Burt Nabors, Michael Salacz, Lynn Taylor, Brian Vaillant, Jaya Gill, and Santosh Kesari

A phase 1 study of AGEN2373, a novel CD137 agonist antibody designed to avoid hepatoxicity, in patients with advanced solid tumors, MA Barve, MH Taylor, and See all authors in comments

Link

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative., Mir B Basir, Alejandro Lemor, Sarah Gorgis, Kirit C Patel, Brian C Kolski, Aditya S Bharadwaj, Joshua W Todd, Behnam N Tehrani, Alexander G Truesdell, David M Lasorda, Thomas A Lalonde, Amir Kaki, Theodore L Schrieber, Nainesh C Patel, Shaun R Senter, Joseph L Gelormini, Steven P Marso, Ayaz M Rahman, Robert E Federici, Charles E Wilkins, A Thomas McRae, Ali Nsair, Christopher P Caputo, Matheen A Khuddus, Juan J Chahin, Allison G Dupont, Andrew M Goldsweig, Michael J Lim, Navin K Kapur, David H W Wohns, Yueren Zhou, Michael J Hacala, and William W O'Neill

Link

Health-care expenditures are less for minimally invasive than open colectomy for colon cancer: A US commercial claims database analysis., Amir L Bastawrous, I-Fan Shih, Yanli Li, Marissa Khalil, Biruk Almaz, and Robert K Cleary

Enhancing Anti-tumor Immunity for the Treatment of Head and Neck Cancer, RB Bell

Enhancing Anti-tumor Immunity for the Treatment of Head and Neck Cancer, RB Bell

Neoadjuvant Immunoradiotherapy Prior to Surgery: Towards a New Paradigm in the Management of Locally Advanced Head and Neck Cancer, RB Bell

State of the Art of Head and Neck Cancer Immunotherapy Translational Research, RB Bell

Development and optimization of a broad hyperplex immunofluorescence assay for tumor immune microenvironment characterization, R Ben-Shimol, Carlo Bifulco, Brian Piening, and See full list of authors in comments

Link

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1., B Besse, E Felip, R Garcia Campelo, M Cobo, C Mascaux, A Madroszyk, F Cappuzzo, W Hilgers, G Romano, F Denis, S Viteri, D Debieuvre, D Galetta, E Baldini, M Razaq, G Robinet, M Maio, A Delmonte, B Roch, P Masson, W Schuette, A Zer, J Remon, D Costantini, B Vasseur, R Dziadziuszko, G Giaccone, ATALANTE-1 study group, and Rachel E Sanborn (ATALANTE-1 study group)

Link

A Rare Case of Demodicosis Following Treatment With Oral Fluconazole., Joshua A Bezecny, Emily Bolton, Matthew H Taylor, and Elizabeth G Berry

Empowering Precision Medicine With Genomics, Multi-Modal AI And Real-World Data, C Bifulco

Spatial Biology: Driving Clinical Trials and Diagnostics in a Multiomics AI-Powered Era, C Bifulco

The overview of Spatial Technologies in the use of Immunopathology, C Bifulco

Transforming Patient Care Through Data and AI, C Bifulco

Spatial Biology as a Tool to reveal Mechanisms of Immune Exclusion, Carlo Bifulco

Spatial Biology in a Multiomics AI-Powered Era, Carlo Bifulco

Spatial Omics in Immunotherapy Trials: Unpacking the Challenges, Carlo Bifulco

Implementing CGP plus HRD testing In-house in a Large US Healthcare System, Carlo Bifulco and Brian Piening

A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799933 (ARRY-440) as a single agent and in combination therapy in participants 16 years and older with advanced solid tumors with BRAF alterations, JTT Black, MH Taylor, and See all authors in comments

Link

Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report., Stephanie V Blank, Warner K Huh, Maria Bell, Sarah Dilley, Melissa Hardesty, Ebony R Hoskins, Jason Lachance, Fernanda Musa, Emily Prendergast, B J Rimel, Mark Shahin, and Fidel Valea

Link

Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041), Bruno Bockorny, Steven O'Day, Kim Margolin, Rachel E Sanborn, Timothy S Kristedja, and See all authors in comments

Link

spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape., Fabio Boniolo, Markus Hoffmann, Norman Roggendorf, Bahar Tercan, Jan Baumbach, Mauro A A Castro, A Gordon Robertson, Dieter Saur, and Markus List

Link

ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial., Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait, Jennifer D Son, Kirsten K Edmiston, Constantine Godellas, Marie C Lee, Michael J Carr, Jennifer E Tonneson, Angelena Crown, Rachel B Lancaster, Hannah E Woriax, Cheryl A Ewing, Harrison S Chau, Anne K Patterson, Jasmine M Wong, Michael D Alvarado, Rachel L Yang, Theresa W Chan, Jori B Sheade, Gretchen M Ahrendt, Kelsey E Larson, Kayla Switalla, Todd M Tuttle, Julia C Tchou, Roshni Rao, Nina Tamirisa, Puneet Singh, Rebekah E Gould, Alicia Terando, Candice Sauder, Kelly Hewitt, Akiko Chiba, Laura J Esserman, and Rita Mukhtar

Link

Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial., Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait, Jennifer D Son, Kirsten K Edmiston, Constantine V Godellas, Marie C Lee, Michael J Carr, Jennifer E Tonneson, Angelena Crown, Rachel B Lancaster, Hannah E Woriax, Cheryl A Ewing, Harrison S Chau, Anne K Patterson, Jasmine M Wong, Michael D Alvarado, Rachel L Yang, Theresa W Chan, Jori B Sheade, Gretchen M Ahrendt, Kelsey E Larson, Kayla Switalla, Todd M Tuttle, Julia C Tchou, Roshni Rao, Nina Tamirisa, Puneet Singh, Rebekah E Gould, Alicia Terando, Candice Sauder, Kelly Hewitt, Akiko Chiba, Laura J Esserman, and Rita A Mukhtar

Link

Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies., Alexis C Boulter, Barry J Maurer, Meredith Pogue, Min H Kang, Hwangeui Cho, Amanda Knight, C Patrick Reynolds, Donald Quick, Sanjay Awasthi, and David E Gerber

Results from an expanded phase 1 trial of botensilimab, a multifunctional anti-CTLA-4, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer, AJ Bullock, RE Sanborn, and See all authors in comments

Lucchesi O, Ruete MC, Mayorga LS, and Tomes CN, MA Bustos

The 16th International Congress of the Society for Melanoma Research (SMR), November 20-23, 2019, MA Bustos

Diagnostic cell-free miRNA Signatures Found in Plasma and Urine of Sporadic Renal Cell Carcinoma Patients, MA Bustos, J Gottlieb, R Suyeon, WM Allen, DL Krasne, TG Wilson, JA Linehan, and DSB Hoon

Link

Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients., Matias A Bustos, Josh Gottlieb, Jane Choe, Suyeon Ryu, Selena Y Lin, Warren M Allen, David L Krasne, Timothy G Wilson, Dave S B Hoon, and Jennifer M Linehan

Link

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer., Matias A Bustos, Takamichi Yokoe, Yoshiaki Shoji, Yuta Kobayashi, Shodai Mizuno, Tomoko Yamazaki, Xiaoqing Zhang, Sreeja C Sekhar, SooMin Kim, Suyeon Ryu, Matthew Knarr, Steven A Vasilev, Analisa DiFeo, Ronny Drapkin, and Dave Hoon

Link

Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer., Jeremie Calais, Stephen M Eulau, Linda Gardner, Ralph J Hauke, Ayse T Kendi, Neal D Shore, and Song Zhao

Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, CJ Calfa, WJ Urba, and See all authors in comments

Link

Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy., Derek John Cappon, Susanna Fang, Kendall Berry, Gina Capone, Gina L Carlton, Mario Chrétien, John Gough, Jacob Kamen, Anne Khoorshed, Andy Miller, Stephen Nelli, M Peter Petric, Frank Tourneur, and Josip J Zic

Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab, Matteo S. Carlino, Matthew H. Taylor, and See all authors in comments

Link

CT275 / 15 - Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors, B Carneiro

Link

CT275 / 15 - Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors, B Carneiro, Rachel E Sanborn, and See full list of authors in comments

Link

New Technology for the Breast Surgeon., Michele Carpenter and Julie Le

Link

Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group., Clara Cerrato, Devin Patel, Riccardo Autorino, Giuseppe Simone, Bo Yang, Robert Uzzo, Francesco Porpiglia, Umberto Capitanio, James Porter, Alp Tuna Beksac, Andrea Minervini, Alessandro Antonelli, Maria Angela Cerruto, Clayton Lau, Akbar Ashrafi, Daniel Eun, Alexandre Mottrie, Carmen Mir, Margaret F Meagher, Dhruv Puri, Mimi Nguyen, Sohail Dhanji, Franklin Liu, Savio D Pandolfo, Alexander Kutikov, Francesco Montorsi, Inderbir S Gill, Chandru Sundaram, Jihad Kaouk, and Ithaar H Derweesh

Link

Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy., Stephen M Chan, Peter J Julien, Peter Kaganjo, Robert McKenna, Charles Forscher, Ronald Natale, Robert N Wolfe, Kristi Butenschoen, Rene J Siegel, and James Mirocha

Link

Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database., Bonny Chau, Elizabeth T Loggers, Lee D Cranmer, Harveshp Mogal, Jeremy M Sharib, Edward Y Kim, Stephanie K Schaub, Kelly G Paulson, Hannah M Linden, Jennifer M Specht, Janice N Kim, Sara H Javid, and Michael J Wagner

Link

A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent., Maharrish Chelladurai, Dan Xu, Sivan Izraely, Shlomit Ben-Menachem, Roman Bengaiev, Orit Sagi-Assif, Weirong Yuan, Metsada Pasmanik Chor, Dave S Hoon, Wuyuan Lu, and Isaac P Witz

Link

Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial., Eric X Chen, Jonathan M Loree, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudharry E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C Wei, Dongsheng Tu, and Chris J O'Callaghan

Link

Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis., Chao Cheng, Wei Hong, Yafang Li, Xiangjun Xiao, James McKay, Younghun Han, Jinyoung Byun, Bo Peng, Demetrios Albanes, Stephen Lam, Adonina Tardon, Chu Chen, Stig E Bojesen, Maria T Landi, Mattias Johansson, Angela Risch, Heike Bickeböller, H-Erich Wichmann, David C Christiani, Gad Rennert, Susanne Arnold, Gary E Goodman, John K Field, Michael Pa Davies, Sanjay S Shete, Loic Le Marchand, Geoffrey Liu, Rayjean J Hung, Angeline S Andrew, Lambertus A Kiemeney, Meng Zhu, Hongbing Shen, Shan Zienolddiny, Kjell Grankvist, Mikael Johansson, Angela Cox, Yun-Chul Hong, Jian-Min Yuan, Philip Lazarus, Matthew B Schabath, Melinda C Aldrich, Paul Brennan, Yong Li, Olga Gorlova, Ivan Gorlov, and Christopher I Amos

HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer, D Chism, Brendan Curti, and See all authors in comments

Link

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial., Byoung Chul Cho, Dong-Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura, Sang-We Kim, Rachel E Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna Minchom, Jong-Seok Lee, Ji-Youn Han, Misako Nagasaka, Joshua K Sabari, Sai-Hong Ignatius Ou, Patricia Lorenzini, Joshua M Bauml, Joshua C Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E Knoblauch, and Keunchil Park

Link

Two-Stage Deep-Learning Classifier for Diagnostics of Lung Cancer Using Metabolites., Ashvin Choudhary, Jianpeng Yu, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny

Link

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study., Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, Ananya Roy, Rodolfo Perini, Donna Vickery, and Scott S Tykodi

Link

Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis., William Chour, Jongchan Choi, Jingyi Xie, Mary E Chaffee, Thomas M Schmitt, Kathryn Finton, Diana C DeLucia, Alexander M Xu, Yapeng Su, Daniel G Chen, Rongyu Zhang, Dan Yuan, Sunga Hong, Alphonsus H C Ng, Jonah Z Butler, Rick A Edmark, Lesley C Jones, Kim M Murray, Songming Peng, Guideng Li, Roland K Strong, John K Lee, Jason D Goldman, Philip D Greenberg, and James R Heath

Link

Clinician-Performed Thyroid Fine Needle Aspiration With On-Site Review Improves Diagnostic Yield., Isabelle Chu, Oliver Bellevue, Joseph C Sniezek, and Nuria Perez-Reyes

Link

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments., Michael D Chuong, Mary Ann Clark, Lauren E Henke, Amar U Kishan, Lorraine Portelance, Parag J Parikh, Michael F Bassetti, Himanshu Nagar, Stephen A Rosenberg, Minesh P Mehta, Tamer Refaat, Justin M Rineer, Adam Smith, Steven Seung, Bassem I Zaki, Martin Fuss, and Raymond H Mak

Link

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors., Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, and Santosh Kesari

Link

Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma, MA Couey, Matthew H Taylor, William L. Redmond, Brady Bernard, Richard Bryan Bell, Carlo Bifulco, Brian D. Piening, Walter Urba, Bernard A Fox, and Rom Leidner

Link

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas., Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Thomas F Gajewski, Martin Gutierrez, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Elisabeth I Heath, John A Thompson, Sahar Ansari, Celine Jacquemont, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, and Juneko E Grilley-Olson

Link

Disparity in Breast Cancer Care: Current State of Access to Screening, Genetic Testing, Oncofertility, and Reconstruction., Angelena Crown, Soudabeh Fazeli, Allison W Kurian, Daniela A Ochoa, and Kathie-Ann Joseph

Link

Pregnancy-associated breast cancer: does timing of presentation affect outcome?, Angelena Crown, Damian McCartan, Michael A Curry, Sujata Patil, Sabrina Kamer, Shari Goldfarb, and Mary L Gemignani

Link

Comparison of robotic versus laparoscopic right colectomy node retrieval in the obese population., Karleigh R Curfman, Jessica M Gowing, Ruben M Lesnick, James M Scanlan, Ulrik G Wallin, John A Griffin, and Laila Rashidi

Link

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas., Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, and David G Kirsch

Link

Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target., Sourat Darabi, Joanne Xiu, Timothy Samec, Santosh Kesari, Jose Carrillo, Sonikpreet Aulakh, Kyle M Walsh, Soma Sengupta, Ashley Sumrall, David Spetzler, Michael Glantz, and Michael J Demeure

Link

Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care., Jaydira Del Rivero, Josh Mailman, Michael W Rabow, Jennifer A Chan, Sarah Creed, Hagen F Kennecke, Janice Pasieka, Jennifer Zuar, Simron Singh, and Lauren Fishbein

Link

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results., Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V Long, Paolo A Ascierto, James Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbe, Gaëlle Quéreux, Friedegund Meier, Brendan Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, and Nikhil I Khushalani

Link

Immunotherapy for brain metastases and primary brain tumors., Anna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, Andrea Anichini, Ramy Ibrahim, Michael Weller, Michael Lahn, Alexander M M Eggermont, Bernard Fox, and Michele Maio

Link

Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation., Marios Dimitriou, Teresa Mortera-Blanco, Magnus Tobiasson, Stefania Mazzi, Madeleine Lehander, Kari Högstrand, Mohsen Karimi, Gunilla Walldin, Monika Jansson, Sofie Vonlanthen, Per Ljungman, Saskia M C Langemeijer, Tetsuichi Yoshizato, Eva S Hellstrom-Lindberg, Petter S Woll, and Sten Eirik W Jacobsen

Link

MDR1-EXPRESSING CD4, Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, and Christine Ménétrier-Caux

Link

Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group., Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, Wesley Yip, Robert G Uzzo, Vitaly Margulis, Matteo Ferro, Ottavio De Cobelli, Zhenjie Wu, Giuseppe Simone, Riccardo Mastroianni, Koon H Rha, Daniel D Eun, Adam C Reese, James R Porter, Ithaar Derweesh, Reza Mehrazin, Giuseppe Rosiello, Riccardo Tellini, Marcus Jamil, Alexander Kenigsberg, Jason M Farrow, William P Schrock, Giovanni Cacciamani, Abhishek Srivastava, Amit S Bhattu, Alexandre Mottrie, Mark L Gonzalgo, Chandru P Sundaram, Firas Abdollah, Andrea Minervini, Riccardo Autorino, and Hooman Djaladat

CD4 and CD8 T cell responses in human solid tumors. Duhen T. Wilske Seminar- Benaroya Research Institute 2023 December 7; Seattle, WA., T Duhen

Link

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study., Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, and Richard L Schilsky

Link

Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)., Anthony B. El-Khoueiry, K A Margolin, Rachel E Sanborn, and See all authors in comments

Link

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial., Espen B Ellingsen, Steven O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S Kristedja, Mohammed Milhem, and Yousef Zakharia

Link

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer., Miquel Ensenyat-Mendez, Javier I J Orozco, Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Jennifer L Baker, Matthew P Salomon, Mercè Martí, Maggie L DiNome, Javier Cortés, and Diego M Marzese

Link

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer., Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope, Fernanda Musa, Robert Mannel, Mark S Shahin, Guilherme H Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A Leath, Lilian T Gien, Emily M Hinchcliff, Shashikant B Lele, Lisa M Landrum, Floor Backes, Roisin E O'Cearbhaill, Tareq Al Baghdadi, Emily K Hill, Premal H Thaker, Veena S John, Stephen Welch, Amanda N Fader, Matthew A Powell, and Carol Aghajanian

Link

Regarding: "Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma," by Faries, Mark et al., Richard Essner and Jennifer Keller

Link

Objective assessment of intraoperative skills for robot-assisted partial nephrectomy (RAPN)., Rui Farinha, Alberto Breda, James Porter, Alexandre Mottrie, Ben Van Cleynenbreugel, Jozef Vander Sloten, Angelo Mottaran, and Anthony G Gallagher

Link

National Cancer Institute Imaging Data Commons: Toward Transparency, Reproducibility, and Scalability in Imaging Artificial Intelligence., Andrey Fedorov, William J R Longabaugh, David Pot, David A Clunie, Steven D Pieper, David L Gibbs, Christopher Bridge, Markus D Herrmann, André Homeyer, Rob Lewis, Hugo J W L Aerts, Deepa Krishnaswamy, Vamsi Krishna Thiriveedhi, Cosmin Ciausu, Daniela P Schacherer, Dennis Bontempi, Todd Pihl, Ulrike Wagner, Keyvan Farahani, Erika Kim, and Ron Kikinis

Link

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial., E Felip, N Altorki, C Zhou, Eric Vallieres, A Martínez-Martí, A Rittmeyer, A Chella, M Reck, O Goloborodko, M Huang, R Belleli, V McNally, M K Srivastava, E Bennett, B J Gitlitz, and H A Wakelee

NKG2A expression on tumor reactive CD8 T cells is induced by IL-12, O Fesneau, J Huang, T Duhen, and See full list of authors in comments

Link

Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma., Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff, Natalie A LaFranzo, Zachary S Bradley, Joey Babbitt, William H Westra, Raymond Hsu, Lincoln Nadauld, Howard Mcleod, Sean D Firth, Brittany Sharp, Josh Fuller, Vera Vavinskaya, Leisa Sutton, Ida Deichaite, Samuel D Bailey, Vlad C Sandulache, Matthew J Rendo, Orlan K Macdonald, Karim Welaya, James L Wade, Andrew W Pippas, Jennifer Slim, Bruce Bank, Steven J Saccaro, Xingwei Sui, Adil Akhtar, Savitha Balaraman, Steven E Kossman, Scott A Sonnier, Todd D Shenkenberg, Warren L Alexander, Katherine A Price, Charles L Bane, Jessica Ley, David N Messina, Jarret I Glasscock, Ezra E W Cohen, Douglas R Adkins, and Eric J Duncavage